ctDNA Association of ctDNA and circulating tumor cells after neoadjuvant chemotherapy with disease recurrence in patients with advanced stage epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.

NCT03517332

Association of ctDNA and circulating tumor cells after neoadjuvant chemotherapy with disease recurrence in patients with advanced stage epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.

Associated Conditions

Ovarian, Fallopian, or Primary Peritoneum Cancer

Principal Investigator

Sponsor

AdventHealth CFD

To compare the levels of ctDNA and CTCs using the SIGNATERA™ test in the peripheral blood of patients during neoadjuvant chemotherapy and after IDS for advanced stage epithelial ovarian carcinoma. Blood samples will be collected from research subjects before and after cytoreductive surgery to determine whether ctDNA levels relate to residual disease.